Top 50 Pharmaceutical Companies & Their Pipelines : Market Research Report

Top 50 Pharmaceutical Companies & Their Pipelines

Published by: Canon Communications, LLC

Published: Sep. 1, 2009 - 226 Pages

Company notes & special report methodology; Introduction and top pipelines Overview; Products to Watch; Healthcare revenue; Healthcare R&D expenditure; Net income; Return on revenue; Market capitalization; Total assets; Shareholders’ equity; Headquarters, year established; Employees; Business segments
INDEX TO PIPELINES: Abbott Laboratories; Alcon Inc.; Allergan Inc.; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca Plc.; Baxter International Inc.; Bayer AG; Biogen Idec Inc.; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Co.; Celgene Corp.; Chugai Pharmaceutical Co.; CSL Ltd.; Daiichi Sankyo Co.; Dainippon Sumitomo Pharma Co.; Eisai Co.; Eli Lilly and Co.; Forest Laboratories Inc.; Genentech Inc.; Genzyme Corp.; Gilead Sciences Inc.; GlaxoSmithKline Plc.; H. Lundbeck AS; Hospira Inc.; Johnson & Johnson; Kyowa Hakko Kirin Co.; Merck & Co.; Merck KGaA; Mitsubishi Tanabe Pharma Corp.; Mylan Inc.; Novartis; Novo Nordisk AS; Nycomed Group; Otsuka Pharmaceutical Group; Pfizer Inc.; Procter & Gamble Co.; Roche; Sanofi-Aventis Group; Schering-Plough Corp.; Shionogi & Co.; Shire Plc.; Solvay SA; Stada Arzneimittel AG; Taisho Pharmaceutical Co.; Takeda Pharmaceutical Co.; Teva Pharmaceutical Industries; UCB SA; Watson Pharmaceuticals Inc.; Wyeth

Abstract

Despite current economic pressures, pharma R&D expenditure during 2008 continued on a trend of annual growth. R&D expenditure among the top 50 companies grew 10.3% to about $112.61 billion compared with 2007. Two thirds of these companies increased R&D investment during the first half of 2009 and this trend is expected to continue for the foreseeable future.

Get your copy of this report to:

Gain insight into factors driving this trend and those that could impact future R&D investment.

Get statistical data and analytical reviews of revenue and investment activity by company.

Identify high growth areas by therapeutic category, status, and region and understand the future impact of current market conditions.

Track potential competitive products and learn how these could affect your company's bottom-line.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Top 50 Pharmaceutical Companies & Their Pipelines

Table of Contents

Abstract